A study links soluble TNF to the biological pathway between head injury and Alzheimer’s, and shows that selectively neutralizing it with XPro1595 prevents injury-induced increases in amyloid pathology. Treated subjects also demonstrated improved early cognitive performance and pain-related outcomes versus controls. The results are promising but appear preclinical/early-stage based on the wording of the article.
A study links soluble TNF to the biological pathway between head injury and Alzheimer’s, and shows that selectively neutralizing it with XPro1595 prevents injury-induced increases in amyloid pathology. Treated subjects also demonstrated improved early cognitive performance and pain-related outcomes versus controls. The results are promising but appear preclinical/early-stage based on the wording of the article.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialOverall Sentiment
moderately positive
Sentiment Score
0.45